Read More Pharma Industry News Amgen submits BLA for Infliximab biosimilar ABP 710 to FDA Amgen Inc. has officially submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyDecember 18, 2018
